Cargando…
Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
BACKGROUND: Cystic fibrosis (CF) is caused by mutations in the CFTR gene that impair the function of CFTR, a cAMP-regulated anion channel. In the small intestine loss of CFTR function creates a dehydrated, acidic luminal environment which is believed to cause an accumulation of mucus, a phenotype ch...
Autores principales: | De Lisle, Robert C, Mueller, Racquel, Roach, Eileen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945989/ https://www.ncbi.nlm.nih.gov/pubmed/20843337 http://dx.doi.org/10.1186/1471-230X-10-107 |
Ejemplares similares
-
Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse
por: De Lisle, Robert C., et al.
Publicado: (2009) -
Lubiprostone stimulates small intestinal mucin release
por: De Lisle, Robert C
Publicado: (2012) -
Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10
por: Norkina, Oxana, et al.
Publicado: (2005) -
Role of Lubiprostone on Gastrointestinal Motility
por: Jun, Jae Yeoul
Publicado: (2013) -
Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)